Stem Cell Review: Allogeneic or Autologous? (EP2)

Description

You are Watching:

Stem Cell Review: Allogeneic or Autologous?

Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection.

This is the Episode 2 of the Stem Cell Review, aired on October 8st, 2009

Reviews

Login or register to write a review

jean-loup romet-lemonne

Created 5 months ago

In the animation titled ALLOGENIC THERAPY which appears at 2’48" into the program, “Patient’s cell” should be replaced by “Healthy donor cells.”

.

Shosh Merchav

Created 5 months ago

Stem Cell Review: Allogeneic or Autologous?

Excellent!

Related Videos

Stem Cell Review: Tools for Drug Screening (EP4)

Stem Cell Review: Tools for Drug Screening (EP4) (16:13)

<all>

Researchers are using stem cells as tools for disease study, drug screening, clinical trial strategy, and personalized medicine. The induced Pluripotent Stem cell (iPS) is giving us a chance to rethink the way we are developing new drugs. These iPS cells are usually created from somatic cells (such as skin), and not embryos or adult stem cells. In creating iPS from patients' diseased cells, scientists can study the disease in vitro, looking for disease phenotypes, applying microenvironmental stress, and testing new drugs. Compared to animal model testing (e.g. mice), this represents a significant breakthrough, that can be used to validate clinical development strategy and test efficacy in specific groups of patients. iPS is bringing a revolution in drug discovery methodology which is being used to bridge genetics, cell biology, and physiology.

 

Stem Cell Review: Tools for Drug Screening (EP4)

Stem Cell Review: Biological Processes & Industrial Production (EP3)

Stem Cell Review: Biological Processes & Industrial Production (EP3) (22:49)

<all>

What are the biological processes that stem cells go through? What are the industrial processes we need to manufacturing? What do we know about cancer stem cells? How do iPS cells fit into the picture vs. embryonic stem cells? In this episode we investigate how the science and research of stem cells is being translated into industrial cell processes to create FDA approvable, and commercializable products. Differentiation, proliferation, migration, retro-differentiation, trans-differentiation, transformation into cancer cells, the role of tumors' micro environments and epigenetics and all reviewed here by the field's foremost experts.

 

Stem Cell Review: Biological Processes & Industrial Productio...

Stem Cell Review: Stem Cells at a Glance (EP1)

Stem Cell Review: Stem Cells at a Glance (EP1) (18:37)

<all>

What are the different types of stem cells? Potential medical applications? Different business models? Ethical and political constraints? This 1st episode of the Stem Cell Review is a good introductory overview of stem cells.

 

Stem Cell Review: Stem Cells at a Glance (EP1)

Credits

In Order of Appearance:


GUESTS

Alan O. Trounson, Ph.D. - California Institute for Regenerative Medicine President

Alan Colman, Ph.D., M.A. - A*STAR Institute of Medical Biology Executive Director, Singapore Stem Cell Consortium (SSCC); Principal Investigator, Institute of Medical Biology

Gregory A. Bonfiglio - Proteus Venture Partners Managing Partner

George Q. Daley, M.D., Ph.D. - Harvard Medical School Samuel E. Lux, IV Chair in Hematology, Director, Stem Cell Transplantation Program, Children's Hospital Boston

Shinya Yamanaka, M.D., Ph.D. - UCSF and Kyoto University Senior Investigator, Gladstone Institute of Cardiovascular Disease, L.K. Whittier Foundation Investigator in Stem Cell Biology; Professor of Anatomy, University of California, San Francisco; Director, Center for iPS Cell Research and Application (CiRA), Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University; Professor, Department of Stem Cell Sciences, Institute for Frontier Medical Sciences

Dan Marshak Ph.D. - PerkinElmer, Inc. Chief Scientific Officer and President, Greater China

John Sinden, Ph.D. - ReNeuron Group Chief Scientific Officer


IMAGES

Jecca: Eyes from "Synapse"

CIRM: Retinal pigment epithelium

CIRM: Human Embryos

monkeybusinessimages: Doctor And Patient Talking

iofoto: Doctor and patient.

Unknown: Human Embryonic Stem Cells

Dr Abhijit Datir : Teratoma Anterior Mediastinal Mass (Reference: Camilla R. Whitten, Sameer Khan, Graham J. Munneke, and Sisa Grubnic A Diagnostic Approach to Mediastinal Abnormalities. RadioGraphics 2007; 27: 657-671.)

CIRM: Retinal pigment epithelium pre


A Special Thanks to:

Ferghana Partners Group

ISSCR / The International Society for Stem Cell Research

Genetics Policy Institute / World Stem Cell Summit

Hilton Hotels / The Hilton Diagonal Mar in Barcelona


MUSIC

Protest by soundroll

Five Tribes by ventilo35


Last but not Least!

- Freya Alugas
- Pat Becker
- Melissa Carpenter
- Ellen Charles
- Meagan Comerford
- Karena Essex
- Elisabet Fabregas
- Mario Fante
- Rocio Fontela
- Liz Freyn
- Don Gibbons
- Raj Kaur
- Paul Laland
- Gemma Llamas
- Jillian McFady
- Mary Lou McKeone
- Didier Montarras
- Mario Oliete
- Jose Maria Ruiz
- Valerie Tucker
- Kristen April Uekermann
- Nancy Witty
- Jessica Yingling

Subscribe

About

The Stem Cell Review is a 10-part series on the science, medical applications, and business of stem cells. This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field. The Stem Cell Review is a BioBusiness.TV Original Production presented by Bill Kridel.

Acknowledgements



Ferghana Partners Group

International Society for Stem Cell Research

Genetics Policy Institute

Hilton Diagonal Mar Barcelona